Nutriband Inc WT (NTRBW)

$1.20 -0.15 (-11.11%)
Market Cap N/A
Revenue (ttm) 2.09M
Net Income (ttm) -5.49M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 11,200
Avg Vol 1,938
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 32%
Beta N/A
Analysts Strong Sell
Price Target N/A

Latest News on NTRBW

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Feb 21, 2025, 7:00 AM EST - 2 days ago

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

NTRB

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Feb 13, 2025, 7:00 AM EST - 10 days ago

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRB

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

Feb 7, 2025, 8:45 AM EST - 16 days ago

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

NTRB

Nutriband Issues Letter to Shareholders

Dec 31, 2024, 7:00 AM EST - 7 weeks ago

Nutriband Issues Letter to Shareholders

NTRB

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Dec 27, 2024, 9:25 AM EST - 2 months ago

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

NTRB

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Dec 4, 2024, 9:00 AM EST - 2 months ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRB

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Nov 27, 2024, 7:00 AM EST - 3 months ago

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

NTRB

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Oct 31, 2024, 8:35 AM EDT - 4 months ago

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

NTRB

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Oct 17, 2024, 7:00 AM EDT - 4 months ago

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

NTRB

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Oct 2, 2024, 7:00 AM EDT - 5 months ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

NTRB

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Sep 24, 2024, 7:00 AM EDT - 5 months ago

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

NTRB

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

Sep 20, 2024, 6:50 AM EDT - 5 months ago

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

NTRB

Nutriband Inc. Authorizes $1M Share Buyback Program

Sep 16, 2024, 4:00 PM EDT - 5 months ago

Nutriband Inc. Authorizes $1M Share Buyback Program

NTRB

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Sep 4, 2024, 7:00 AM EDT - 6 months ago

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRB

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

Jul 19, 2024, 7:00 AM EDT - 7 months ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

NTRB

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

Jul 15, 2024, 7:00 AM EDT - 7 months ago

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

NTRB

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

Jun 20, 2024, 7:00 AM EDT - 8 months ago

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

NTRB

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

Jun 3, 2024, 7:00 AM EDT - 9 months ago

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

NTRB

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

May 16, 2024, 7:00 AM EDT - 10 months ago

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

NTRB

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

Apr 23, 2024, 7:00 AM EDT - 10 months ago

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

NTRB

Nutriband Inc. Announces $8.4M Private Placement

Apr 19, 2024, 7:00 AM EDT - 11 months ago

Nutriband Inc. Announces $8.4M Private Placement

NTRB

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

Mar 25, 2024, 7:00 AM EDT - 11 months ago

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

NTRB

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

Mar 4, 2024, 7:00 AM EST - 1 year ago

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

NTRB

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

Jan 29, 2024, 7:00 AM EST - 1 year ago

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

NTRB

Nutriband CEO Publishes Letter to Shareholders

Jan 26, 2024, 7:00 AM EST - 1 year ago

Nutriband CEO Publishes Letter to Shareholders

NTRB

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

Nov 28, 2023, 7:00 AM EST - 1 year ago

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

NTRB

Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape

Nov 8, 2023, 7:00 AM EST - 1 year ago

Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape

NTRB

Nutriband's Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

Oct 11, 2023, 7:42 AM EDT - 1 year ago

Nutriband's Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

NTRB

Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

Sep 20, 2023, 7:30 AM EDT - 1 year ago

Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

NTRB

Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

Sep 11, 2023, 7:00 AM EDT - 1 year ago

Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

NTRB

Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador

Aug 30, 2023, 8:00 AM EDT - 1 year ago

Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador

NTRB

Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

Jul 27, 2023, 8:30 AM EDT - 1 year ago

Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

NTRB

Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission

Jul 14, 2023, 9:20 AM EDT - 1 year ago

Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission

NTRB

Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology

Jun 23, 2023, 7:00 AM EDT - 1 year ago

Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology

NTRB

Nutriband to Attend 2023 BIO International Convention

May 10, 2023, 8:00 AM EDT - 1 year ago

Nutriband to Attend 2023 BIO International Convention

NTRB

Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023

Apr 27, 2023, 8:00 AM EDT - 1 year ago

Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023

NTRB

Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023

Apr 19, 2023, 7:00 AM EDT - 2 years ago

Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023

NTRB

Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology

Mar 28, 2023, 8:00 AM EDT - 2 years ago

Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology

NTRB

Nutriband Inc Joins Webull Corporate Communications Service Platform

Mar 8, 2023, 8:00 AM EST - 2 years ago

Nutriband Inc Joins Webull Corporate Communications Service Platform

NTRB

Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee

Mar 2, 2023, 8:00 AM EST - 2 years ago

Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee

NTRB

Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register

Feb 15, 2023, 6:00 AM EST - 2 years ago

Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register

NTRB

Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference

Jan 24, 2023, 6:00 AM EST - 2 years ago

Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference

NTRB

Nutriband Inc. Commences Trading on Upstream Under NTRB

Jan 5, 2023, 6:00 AM EST - 2 years ago

Nutriband Inc. Commences Trading on Upstream Under NTRB

NTRB

Nutriband Inc. Will Be the First Company to Dual List on Upstream

Dec 30, 2022, 6:30 AM EST - 2 years ago

Nutriband Inc. Will Be the First Company to Dual List on Upstream

NTRB

Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023

Dec 29, 2022, 6:30 AM EST - 2 years ago

Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023

NTRB

Nutriband Approved for Dual Listing on Upstream

Dec 14, 2022, 7:00 AM EST - 2 years ago

Nutriband Approved for Dual Listing on Upstream

NTRB

Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

Dec 14, 2022, 6:00 AM EST - 2 years ago

Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

NTRB

Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3

Dec 5, 2022, 7:00 AM EST - 2 years ago

Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3

NTRB

Nutriband Inc to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022

Dec 2, 2022, 7:00 AM EST - 2 years ago

Nutriband Inc to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022

NTRB

Nutriband Receives Notice of Issuance from the Canadian Intellectual Property Office for its AVERSA(TM) Abuse Deterrent Transdermal Technology Patent

Dec 1, 2022, 7:00 AM EST - 2 years ago

Nutriband Receives Notice of Issuance from the Canadian Intellectual Property Office for its AVERSA(TM) Abuse Deterrent Transdermal Technology Patent

NTRB